1. Home
  2. AMCX vs NAUT Comparison

AMCX vs NAUT Comparison

Compare AMCX & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$9.80

Market Cap

339.5M

ML Signal

HOLD

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$1.96

Market Cap

252.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
NAUT
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Laboratory Analytical Instruments
Sector
Telecommunications
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
339.5M
252.6M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
AMCX
NAUT
Price
$9.80
$1.96
Analyst Decision
Sell
Analyst Count
5
0
Target Price
$6.50
N/A
AVG Volume (30 Days)
416.2K
240.4K
Earning Date
02-13-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,316,303,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$0.62
52 Week High
$10.60
$2.54

Technical Indicators

Market Signals
Indicator
AMCX
NAUT
Relative Strength Index (RSI) 65.24 53.16
Support Level $9.49 $1.91
Resistance Level $9.91 $2.07
Average True Range (ATR) 0.34 0.14
MACD -0.05 -0.02
Stochastic Oscillator 61.55 54.17

Price Performance

Historical Comparison
AMCX
NAUT

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: